Osteoporosis Management Strategies in the COVID-19 Pandemic

Authors: Vishnu Sundaresh,MD, MS


Coronavirus disease 2019 (COVID-19) has led to active infections and relatively high morbidity and mortality across the world, including the United States.1 The pandemic has challenged the US healthcare system, and rapid treatment adaptations have had to be made to stabilize public health and provide effective medical care.
Posted in: Infectious Disease42 Metabolic & Other Bone Disease (Osteoporosis)6

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.


1. Omer SB, Malani P, Del Rio C. The COVID-19 pandemic in the US: a clinical update. JAMA 2020;323:1767–1768. 2. Keesara S, Jonas A, Schulman K. COVID-19 and health care’s digital revolution. N Engl J Med 2020;382:e82. 3. Centers for Disease Control and Prevention. Public health professionals gateway. State and territorial health department websites. Accessed April 27, 2020. 4. Centers for Medicare & Medicaid Services. Medicare telemedicine health care provider fact sheet. Published March 17, 2020. Accessed April 27, 2020. 5. Eastell R, Rosen CJ, Black DM, et al. Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2019;104:1595–1622. 6. National Osteoporosis Foundation. Ask the Expert: Dr. Lewiecki Shares Invaluable Insight on Best Telemedicine Practices During the Pandemic. Accessed April 27, 2020.